Lexaria Bioscience Ownership | Who Owns Lexaria Bioscience?

Lexaria Bioscience Ownership Summary

Lexaria Bioscience is owned by 9.39% institutional investors, 6.42% insiders, and 84.20% retail investors. Invenomic capital management lp is the largest institutional shareholder, holding 2.61% of LEXX shares. Invenomic Institutional is the top mutual fund, with 1.42% of its assets in Lexaria Bioscience shares.

LEXX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lexaria Bioscience	9.39%	6.42%	84.20%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Invenomic capital management lp	477.20K	2.61%	$454.63K
Murchinson	419.59K	2.29%	$399.74K
Vanguard group	258.82K	1.41%	$246.65K
Geode capital management	174.78K	0.96%	$166.55K
Toronto dominion bank	140.01K	0.77%	$133.50K
Raymond james financial services advisors	48.80K	0.35%	$135.66K
State street	39.30K	0.21%	$37.44K
Blackrock	27.45K	0.20%	$76.30K
Wealth enhancement advisory services	35.78K	0.20%	$29.93K
Byrne asset management	31.32K	0.17%	$29.84K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Murchinson	419.59K	0.05%	$399.74K
Invenomic capital management lp	477.20K	0.02%	$454.63K
Byrne asset management	31.32K	0.02%	$29.84K
Virtu financial	29.36K	0.00%	$28.00K
Krilogy financial	19.65K	0.00%	$21.23K
Raymond james financial services advisors	48.80K	0.00%	$135.66K
Toronto dominion bank	140.01K	0.00%	$133.50K
Tower research capital llc (trc)	3.62K	0.00%	$3.45K
Federation des caisses desjardins du quebec	382.00	-	$362.00
Sound income strategies	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Murchinson	419.59K	0.05%	419.59K
Vanguard group	258.82K	-	125.26K
Virtu financial	29.36K	0.00%	29.36K
Blackrock	27.45K	-	25.94K
Krilogy financial	19.65K	0.00%	19.65K

Top Sellers

Holder	Shares	% Assets	Change
Sabby management	-	-	-1.17M
Armistice capital	-	-	-460.00K
Raymond james financial	-	-	-61.25K
Gentrust	-	-	-60.00K
Invenomic capital management lp	477.20K	0.02%	-24.27K

New Positions

Holder	Shares	% Assets	Change	Value
Murchinson	419.59K	0.05%	419.59K	$399.74K
Virtu financial	29.36K	0.00%	29.36K	$28.00K
Krilogy financial	19.65K	0.00%	19.65K	$21.23K
Renaissance	10.10K	-	10.10K	$9.62K
Citigroup	429.00	-	429.00	$409.00

Sold Out

Holder	Change
Northwestern mutual wealth management	-9.00
Sound income strategies	-22.00
Allworth financial lp	-89.00
Mather group, llc.	-100.00
Aspire private capital	-400.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	25	19.05%	1,717,330	-25.25%	9	5.95%	13	44.44%	2	-
Jun 30, 2025	21	-4.55%	2,297,063	85.28%	12	25.05%	8	-20.00%	3	-25.00%
Mar 31, 2025	1	-96.00%	549,947	-61.85%	3	4.20%	1	-92.31%	-	-100.00%
Dec 31, 2024	25	-7.41%	1,426,411	33.73%	8	14.44%	12	9.09%	2	-50.00%
Sep 30, 2024	26	-7.14%	1,061,074	-48.44%	7	3.47%	10	-28.57%	4	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Invenomic Institutional	276.79K	1.42%	77.77K
Vanguard Institutional Extnd Mkt Idx Tr	126.64K	0.65%	3.29K
Fidelity Extended Market Index	86.21K	0.44%	-710.00
BlackRock Extended Equity Market K	22.61K	0.14%	-10.00
Fidelity Total Market Index	26.29K	0.13%	-
Fidelity Series Total Market Index	22.20K	0.11%	-
Extended Equity Market Fund K	21.93K	0.11%	-438.00
Spartan Extended Market Index Pool E	17.81K	0.10%	755.00
Spartan Extended Market Index Pool F	19.54K	0.10%	710.00
Northern Trust Extended Eq Market Idx	12.25K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 30, 2025	BUNKA CHRISTOPHER	-	Buy	$10.87K
Jul 29, 2025	BUNKA CHRISTOPHER	-	Buy	$14.38K
Jul 29, 2025	McKechnie William Edward	-	Buy	$4.53K
Jul 29, 2025	DOCHERTY JOHN MARTIN	President & CSO	Buy	$4.99K
Jul 29, 2025	Carle Vanessa	Secretary	Buy	$682.50

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	6	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q3	1	1
2024 Q2	-	-

LEXX Ownership FAQ

Who Owns Lexaria Bioscience?

Lexaria Bioscience shareholders are primarily institutional investors at 9.39%, followed by 6.42% insiders and 84.19% retail investors. The average institutional ownership in Lexaria Bioscience's industry, Biotech Stocks , is 45.22%, which Lexaria Bioscience falls below.

Who owns the most shares of Lexaria Bioscience?

Lexaria Bioscience’s largest shareholders are Invenomic capital management lp (477.2K shares, 2.61%), Murchinson (419.59K shares, 2.29%), and Vanguard group (258.82K shares, 1.41%). Together, they hold 6.32% of Lexaria Bioscience’s total shares outstanding.

Does Blackrock own Lexaria Bioscience?

Yes, BlackRock owns 0.20% of Lexaria Bioscience, totaling 27.44K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 76.3K$. In the last quarter, BlackRock increased its holdings by 25.94K shares, a 1719.96% change.

Who is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested?

Murchinson is Lexaria Bioscience’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 419.59K Lexaria Bioscience shares, valued at 399.74K$.

Who is the top mutual fund holder of Lexaria Bioscience shares?

Invenomic Institutional is the top mutual fund holder of Lexaria Bioscience shares, with 1.42% of its total shares outstanding invested in 276.79K Lexaria Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools